Clincosm LogoSign in Get a demo

diabetes mellitus, type 2

Showing NaN - NaN of 235
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +98 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin degludec, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Birmingham, Alabama
  • +165 more
Apr 30, 2019

Diabetes, Type 2 Trial in Worldwide (Placebo, Linagliptin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Huntsville, Alabama
  • +648 more
Mar 21, 2019

Diabetes, Type 2 Trial in Canada, United States (ITCA 650 20/60 mcg/day, Empagliflozin (oral), Glimepiride (oral))

Terminated
  • Diabetes Mellitus, Type 2
  • ITCA 650 20/60 mcg/day
  • +2 more
  • Fountain Hills, Arizona
  • +100 more
Mar 4, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Faster-acting insulin aspart
  • +2 more
  • Glendale, Arizona
  • +143 more
Jan 10, 2019

Diabetes, Type 2 Trial in Dallas (LY2409021, Placebo, Moxifloxacin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Dallas, Texas
    For additional information regarding investigative sites for thi
Dec 13, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, liraglutide, exenatide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Birmingham, Alabama
  • +108 more
Dec 7, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin glargine
  • Fresno, California
  • +90 more
Dec 7, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin degludec
  • Huntsville, Alabama
  • +85 more
Dec 7, 2018

Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • +2 more
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +312 more
Nov 5, 2018

Diabetes, Type 2 Trial in Worldwide (Bolus Insulin Patch (Calibra Finesse), Insulin Pen (Novo-Nordisk FlexPen®))

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Bolus Insulin Patch (Calibra Finesse)
  • Insulin Pen (Novo-Nordisk FlexPen®)
  • Phoenix, Arizona
  • +51 more
Nov 6, 2018

Diabetes, Type 2 Trial in United States (ITCA 650 Osmotic Mini Pump 20/60 mcg/day, ITCA 650 Osmotic Mini Pump 60 mcg/day,

Completed
  • Diabetes Mellitus, Type 2
  • ITCA 650 Osmotic Mini Pump 20/60 mcg/day
  • +3 more
  • Birmingham, Alabama
  • +35 more
Nov 1, 2018

Diabetes, Type 2 Trial in Puerto Rico, United States (Insulin glargine, Inhaled Insulin (Exubera))

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin glargine
  • Inhaled Insulin (Exubera)
  • Phoenix, Arizona
  • +72 more
Aug 31, 2018

Diabetes, Type 2 Trial in Worldwide (Insulin glargine, 300U/mL, Insulin degludec, 100 U/mL, Non-insulin anti-diabetic treatment)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin glargine, 300U/mL
  • +2 more
  • Sheffield, Alabama
  • +157 more
Aug 14, 2018

Diabetes, Diabetes, Type 2 Trial in United States (rosiglitazone, inhaled human insulin, metformin)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Hueytown, Alabama
  • +102 more
Sep 3, 2018

Diabetes, Diabetes, Type 2 Trial in United States (pioglitazone, inhaled human insulin)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Ozark, Alabama
  • +109 more
Sep 3, 2018

Diabetes, Type 2 Trial in United States (Placebo, LY2922470)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Chula Vista, California
  • +3 more
Jul 25, 2018

Diabetes, Type 2 Trial in Worldwide (, linagliptin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Sheffield, Alabama
  • +144 more
Jun 1, 2018

Diabetes, Type 2 Trial in United States (Exenatide once weekly suspension, Exenatide twice daily)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Exenatide once weekly suspension
  • Exenatide twice daily
  • Muscle Shoals, Alabama
  • +57 more
Jun 4, 2018

Diabetes, Type 2 Trial in Worldwide (GSK523338)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Tucson, Arizona
  • +84 more
Apr 2, 2018

Diabetes, Type 2 Trial in Worldwide (LY2605541, insulin glargine)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Idaho Falls, Idaho
  • +24 more
May 4, 2018

Diabetes, Type 2 Trial in Worldwide (LY2605541, Insulin glargine)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Mesa, Arizona
  • +60 more
Mar 17, 2018

Diabetes, Type 2 Trial in Worldwide (LY2605541, Insulin Glargine, Insulin Lispro)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Mobile, Alabama
  • +155 more
Mar 16, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/insulin aspart
  • Goodyear, Arizona
  • +44 more
Mar 6, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/insulin aspart, insulin degludec, insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/insulin aspart
  • +2 more
  • Greenbrae, California
  • +50 more
Mar 6, 2018